Audio

Dawn Buse, PhD, and Richard Lipton, MD, Describe the Effects of Modifying a Migraine Treatment Regimen

Neurology Reviews. 2012 October;20(10):80

 

To read the accompanying article, please click here.

Recommended Reading

Elizabeth Loder, MD, MPH, President of the American Headache Society, Is Interviewed by International Headache Society President-Elect and Neurology Reviews Editor-in-Chief Alan Rapoport, MD.
MDedge Neurology
Does Changing Migraine Therapy Cause More Harm Than Good?
MDedge Neurology
Patients' Migraine Treatment Regimens May Not Be Optimized
MDedge Neurology
COMMENTARY by Alan M. Rapoport, MD—A Call for Better Migraine Medications
MDedge Neurology
COMMENTARY by Alan M. Rapoport, MD—An Uncommon Problem Receives Needed Attention
MDedge Neurology
UK Guideline Describes Medication Overuse Headache
MDedge Neurology
Migraine-Related Hyperintensities May Not Be Associated With Cognitive Decline
MDedge Neurology
Depression Is Associated With Transformation of Episodic to Chronic Migraine
MDedge Neurology
COMMENTARY—Variations on a Theme: Detoxifying Patients With Medication Overuse Headache
MDedge Neurology
A Standard Protocol for Medication Overuse Headache?
MDedge Neurology